Evidence map›Paper›PMID 29286310›Full record

ArticleMaterials (Basel, Switzerland)2017

Formation Mechanism and Dispersion of Pseudo-Tetragonal BaTiO₃-PVP Nanoparticles from Different Titanium Precursors: TiCl₄ and TiO₂.

Jinhui Li, Koji Inukai, Yosuke Takahashi, Akihiro Tsuruta, Woosuck Shin

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jinhui LiDepartment of Frontier Materials, Nagoya Institute of Technology, Nagoya 466-8555, Japan. kinki-ri@aist.go.jp.
Koji InukaiR & D Center, Noritake Co., Ltd., Miyoshi 470-0293, Japan. koujiinukai@n.noritake.co.jp.
Yosuke TakahashiR & D Center, Noritake Co., Ltd., Miyoshi 470-0293, Japan. yosuke-takahashi@n.noritake.co.jp.
Akihiro TsurutaInorganic Functional Material Research Institute AIST, Nagoya 463-8560, Japan. a.tsuruta@aist.go.jp.
Woosuck ShinDepartment of Frontier Materials, Nagoya Institute of Technology, Nagoya 466-8555, Japan. w.shin@aist.go.jp.
Nagoya Institute of Technology · JPNoritake (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nano-sized tetragonal BaTiO₃ (BT) particles that are well dispersed in solution are essential for the dielectric layer in multilayer ceramic capacitor technology. A hydrothermal process using TiCl₄ and BaCl₂, as source of Ti and Ba, respectively, or the precursor TiO₂ as seed for the formation of BT, and poly(vinylpyrrolidone) (PVP) as a surfactant, was employed in this study to enhance both the dispersibility and tetragonality (c/a) simultaneously in a single reaction process. The process parameters, i.e., the ratio of TiO₂ substitution of TiCl₄, the reaction time, and PVP content were systematically studied, and the growth mechanism and relation between the tetragonality and the particle size are discussed. Dynamic light scattering (DLS) analysis was used to show that truncated pseudo-tetragonal BT-PVP particles with an average size of 100 nm, having a narrow size distribution and a coefficient of variation (CV) as low as 20% and being mono-dispersed in water, were produced. The narrow particle size distribution is attributed to the ability of PVP to inhibit the growth of BT particles, and the high c/a of BT-PVP to heterogeneous particle growth using TiO₂ seeds.

Indexed as

BaTiO3c/adispersionhydrothermalpoly(vinylpyrrolidone)

Identifiers

PMID29286310
PMCPMC5793549
OpenAlexW2777491845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.